MRI of Uveal Melanoma

被引:51
|
作者
Ferreira, Teresa A. [1 ]
Fonk, Lorna Grech [1 ,2 ]
Jaarsma-Coes, Myriam G. [1 ,2 ]
van Haren, Guido G. R. [1 ]
Marinkovic, Marina [2 ]
Beenakker, Jan-Willem M. [1 ,2 ]
机构
[1] Leiden Univ, Dept Radiol, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Dept Ophthalmol, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
来源
CANCERS | 2019年 / 11卷 / 03期
关键词
uveal melanoma; MRI; diffusion-weighted imaging; perfusion-weighted imaging; HIGH-RESOLUTION MRI; THERAPY; BENIGN;
D O I
10.3390/cancers11030377
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uveal Melanoma (UM) is the most common primary malignant ocular tumor. The high soft tissue contrast and spatial resolution, and the possibility of generating 3D volumetric and functional images, make Magnetic Resonance Imaging (MRI) a valuable diagnostic imaging technique in UM. Current clinical MRI protocols, however, are not optimized for UM and therefore lack the quality for accurate assessments. We therefore developed a dedicated protocol at a 3 Tesla MRI, using an eye coil, consisting of multi-slice 2D sequences, different isotropic sequences and diffusion and perfusion-weighted images. This protocol was prospectively evaluated in 9 uveal melanoma patients. The multi-slice 2D sequences had the highest in-plane resolution, being the most suited for lesion characterization and local extension evaluation. The isotropic 3D Turbo-Spin Echo (TSE) sequences were the most suitable for accurate geometric measurements of the tumor and are therefore important for therapy planning. Diffusion and perfusion-weighted images aid in differentiating benign from malignant lesions and provide quantitative measures on tumor hemodynamics and cellularity, which have been reported to be effective in predicting and assessing treatment outcome. Overall, this dedicated MRI protocol provides high-quality imaging of UM, which can be used to improve its diagnosis, treatment planning, and follow-up.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Clinical indications for an MRI for Uveal Melanoma patients
    Beenakker, J. W. M.
    Ferreira, T. A.
    Jaarsma-Coes, M. G.
    Vu, T. H. K.
    Marinkovic, M.
    Luyten, G. P. M.
    ACTA OPHTHALMOLOGICA, 2022, 100 : 41 - 41
  • [2] MRI VERSUS CT IN THE DIAGNOSIS OF UVEAL MELANOMA
    MONTEIROGRILLO, M
    MAGRO, P
    MARQUESNEVES, C
    MONTEIROGRILLO, L
    COUTINHO, D
    SOUSALE, J
    RIBEIRODASILVA
    VISION RESEARCH, 1995, 35 : 3242 - 3242
  • [3] Predicting the response of uveal melanoma to immunotherapy with MRI assessments
    Moreira, Alvaro
    Saake, Marc
    Schuler, Gerold
    Heinzerling, Lucie
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [4] Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma
    Francis, Jasmine H.
    Catalanotti, Federica
    Landa, Jonathan
    Barker, Christopher A.
    Shoushtari, Alexander N.
    Abramson, David H.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (09) : 1266 - 1271
  • [6] Uveal Melanoma
    Pfeffer, Ulrich
    CANCERS, 2019, 11 (12)
  • [7] UVEAL MELANOMA
    BOAZIZ, C
    MAZERON, JJ
    MORERE, JF
    BREAU, JL
    ISRAEL, L
    BULLETIN DU CANCER, 1993, 80 (07) : 577 - 583
  • [8] Uveal melanoma
    Spagnolo, Francesco
    Caltabiano, Graziano
    Queirolo, Paola
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 549 - 553
  • [9] UVEAL MELANOMA
    CONLON, MR
    ALBERT, DM
    INTERNATIONAL OPHTHALMOLOGY CLINICS, 1993, 33 (02) : 67 - 76
  • [10] Uveal melanoma
    Martine J. Jager
    Carol L. Shields
    Colleen M. Cebulla
    Mohamed H. Abdel-Rahman
    Hans E. Grossniklaus
    Marc-Henri Stern
    Richard D. Carvajal
    Rubens N. Belfort
    Renbing Jia
    Jerry A. Shields
    Bertil E. Damato
    Nature Reviews Disease Primers, 6